Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
| 16:00 |
404-04-001.
Introduction
Giulia Debiasi
University of California, Berkeley, United States of America |
||
| 16:11 |
|
404-04-002.
Quantitative Susceptibility Mapping-Based Substantia Nigra Volumetry for Differential Diagnosis of Parkinsonism
Impact: Quantitative susceptibility mapping-based substantia nigra volumetry significantly improves differentiation between progressive supranuclear palsy and multiple system atrophy compared to conventional T1-based morphometry, highlighting its potential as a valuable biomarker for the currently challenging task of differential diagnosis of parkinsonian syndromes.
|
|
| 16:22 |
|
404-04-003.
Data-driven staging and subtyping reveal spatiotemporal trajectories of brain iron in Parkinson’s disease
Impact: This work establishes a data-driven framework to disentangle Parkinson’s disease heterogeneity, revealing biologically meaningful spatiotemporal trajectories of iron accumulation that may enable personalized disease staging, progression tracking, and biomarker-based patient stratification in clinical trials.
|
|
| 16:33 |
|
404-04-004.
Iron mapping in Parkinson’s disease using deep learning-enhanced susceptibility source separation
Impact: Deep
learning–enhanced χ-separation generated biologically interpretable,
iron-specific susceptibility maps that revealed cortical and nigral
abnormalities in Parkinson’s disease that were not detected by standard QSM.
This approach may provide reliable progression markers and treatment-monitoring
endpoints for neuroprotective and circuit-targeted interventions.
|
|
| 16:44 |
|
404-04-005.
Brain iron varies with brain penetration capabilities of iron chelators: deferiprone vs deferasirox
Impact: Iron chelation is a potential therapy for patients with brain iron accumulation associated with neurodegeneration. We measured brain iron using QSM for two commonly used chelators and demonstrated lower levels in patients taking deferiprone compared to patients taking deferasirox.
|
|
| 16:55 |
|
404-04-006.
Revisiting the Role of Tyrosinase in Human Neuromelanin Formation Using NM-MRI in Oculocutaneous Albinism Type 1
Impact: Our findings suggest that NM synthesis in the
human brain is not driven by tyrosinase. Identifying alternative enzymatic or
spontaneous oxidative pathways may advance understanding of dopaminergic neuron
biology and provide new targets for neuroprotection in Parkinson’s disease.
|
|
| 17:06 |
|
404-04-007.
Comparing the Vascular density and iron deposition for the thalamus subnuclei using USPIO-MRI and QSM at 3T
Impact: The combination
of thalamic structure, vasculature, and iron metabolism offers a powerful
framework to differentiate normative aging from early neurovascular pathology that will be further
investigated in neurological and neuropsychiatric disorders.
|
|
| 17:17 |
|
404-04-008.
Quantitative Susceptibility Mapping Detects Progressive Iron Accumulation in Early MSA
Impact: QSM, especially P75 and patient-level z-score mapping, offers a scalable biomarker to detect and track iron dysregulation in early MSA, enabling earlier diagnosis, objective monitoring, and evaluation of iron-modulating therapeutic interventions.
|
|
| 17:28 |
|
404-04-009.
Integrated Iron and Neuron-Glial Metabolism Predict Functional Outcome After Ischemic Stroke with Simultaneous QSM–MRSI
Impact: Simultaneous QSM–MRSI provides an integrated view of
iron, neuronal, and glial alterations after stroke. By revealing iron-driven
oxidative–metabolic coupling as a useful predictor of early recovery, simultaneous
QSM–MRSI provides a multimodal biomarker for prognosis and targeted
neuroprotective interventions.
|
|
| 17:39 |
|
404-04-010.
Longitudinal Imaging of Iron and Myelin Maturation in Contact-Sport Athletes Using Source-Separated QSM
Impact: Source-separated
QSM identifies sport- and time-dependent differences in brain susceptibility,
highlighting its value for examining longitudinal microstructural changes
associated with varying levels of contact exposure.
|
© 2026 International Society for Magnetic Resonance in Medicine